ArticleJournal of clinical medicine2025

Does the Use of Denosumab in Combination with bDMARDs or tsDMARDs Increase the Risk of Infection in Patients with Osteoporosis and Inflammatory Rheumatic Diseases?

Salim Mısırcı et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.